[Congressional Record Volume 169, Number 99 (Wednesday, June 7, 2023)]
[Extensions of Remarks]
[Page E533]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




      COMMEMORATING THE GEMINIBIO REED AVE. FACILITY GRAND OPENING

                                 ______
                                 

                          HON. DORIS O. MATSUI

                             of california

                    in the house of representatives

                        Wednesday, June 7, 2023

  Ms. MATSUI. Mr. Speaker, I rise today to commemorate GeminiBio's Reed 
Facility Grand Opening. I ask my colleagues to rise and join me in 
celebration of this new facility. Gemini Bio-Products LLC is an FDA-
registered provider of biological products and chemical reagents to the 
global cell culture community.
  Founded in 1985, GeminiBio serves the global biotechnology industry, 
from basic research to commercial production, with a focus on helping 
customers accelerate the development of life enhancing biotherapeutics 
by streamlining and improving their cell culture and process liquid 
manufacturing workflows. The company's products are organized into two 
core verticals--Cell Culture Solutions and Process Liquid Solutions.
  Located in West Sacramento, California, GeminiBio has invested in 
three distinct expansion projects starting in 2019 and now has 57,000 
square feet of cGMP manufacturing space segregated between animal 
origin-free and animal component manufacturing. In Q1 of 2023, 
GeminiBio finished its 25,000 square foot cGMP facility that is 
dedicated to upstream and downstream media and buffer manufacturing. In 
May of 2023, GeminiBio opened their new 32,000 square foot fully 
validated cGMP facility--warehouse and manufacturing space. GeminiBio 
is an ISO 13485 certified, FDA registered Class 1 Medical Device 
Manufacturer, aligned with 21 CFR Part 820.
  Throughout its growth, GeminiBio has maintained the personalized 
service on which its reputation was built. GeminiBio is committed to 
manufacturing and providing customers with products that consistently' 
meet or exceed all industry and regulatory requirements or 
expectations.
  Mr. Speaker, today I am proud to continue to advocate for Greater 
Sacramento region's growing biotech and cell and gene therapy 
industries and we celebrate the Grand Opening of GeminiBio's Reed Ave. 
Facility. I thank all those involved for investing in our community.

                          ____________________